Location: Dallas, TX
CIK: 0002106181 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 19, 2026
Total Value: $174M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc | 685,644 | $6.699M | 3.9% | $9.77 | $9.77 | — | COM NEW | 48576U205 |
| IFRX | Inflarx Nv | 2,897,769 | $6.491M | 3.7% | $2.24 | $2.24 | — | COM | N44821101 |
| CYCN | Cyclerion Therapeutics Inc | 1,651,350 | $5.598M | 3.2% | $3.39 | $3.39 | — | COM | 23255M204 |
| ANL | Adlai Nortye | 226,415 | $2.604M | 1.5% | $11.50 | $11.50 | — | SPONSORED ADS | 00704R109 |
| NVCT | Nuvectis Pharma Inc | 100,000 | $1.839M | 1.1% | $18.39 | $18.39 | — | COM | 67080T108 |
| MIST | Milestone Pharmaceuticals Inc | 1,269,237 | $1.701M | 1.0% | $1.34 | $1.34 | — | COM | 59935V107 |
| ATYR | Atyr Pharma Inc | 1,788,167 | $1.067M | 0.6% | $0.60 | $0.60 | — | COM NEW | 002120202 |
| TCRX | Tscan Therapeutics Inc | 454,876 | $446K | 0.3% | $0.98 | $0.98 | — | COM | 89854M101 |
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| BOXX | EA SERIES TRUST | 226,188 (+91.0%) | $26.48M (+92.3%) | 15.2% | $117.09 | $116.05 | — | ALPHA ARCH 1-3 | 02072L565 |
| MANE | Veradermics Inc | 145,695 (+41.6%) | $17.91M (+175.7%) | 10.3% | $122.94 | $80.72 | — | COOMON STOCK | 922967104 |
| ACRS | Aclaris Therapeutics Inc | 1,832,365 (+37.0%) | $9.693M (+93.3%) | 5.6% | $5.29 | $3.86 | — | COM | 00461U105 |
| KRRO | Korro Bio Inc | 405,040 (+270.3%) | $5.338M (+331.2%) | 3.1% | $13.18 | $12.54 | — | COM | 500946108 |
| IKT | Inhibikase Therapeutics Inc | 3,821,890 (+43.0%) | $7.758M (+72.8%) | 4.5% | $2.03 | $1.76 | — | COM NEW | 45719W205 |
| GOSS | Gossamer Bio Inc | 11,149,363 (+49.2%) | $1.835M (-25.2%) | 1.1% | $0.16 | $1.57 | — | COM | 38341P102 |
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| RLAY | Relay Therapeutics Inc | 901,457 | $8.969M | 5.2% | $9.95 | $7.14 | — | — | 75943R102 |
| ORKA | Oruka Therapeutics Inc | 118,524 | $5.814M | 3.3% | $49.05 | $27.86 | — | — | 687604108 |
| TNYA | Tenaya Therapeutics Inc | 2,000,000 | $1.385M | 0.8% | $0.69 | $1.36 | — | — | 87990A106 |
| PEPG | PepGen Inc | 729,961 | $1.292M | 0.7% | $1.77 | $5.83 | — | — | 713317105 |
| KLRS | Kalaris Therapeutics Inc | 135,585 | $782K | 0.4% | $5.77 | $6.39 | — | — | 482929106 |
| DMAC | DiaMedica Therapeutics Inc | 62,488 | $423K | 0.2% | $6.77 | $7.48 | — | — | 25253X207 |
| LOOP | LONGEVERON INC | 347,539 | $361K | 0.2% | $1.04 | $1.20 | — | — | 543518104 |
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| TIL | Instil Bio Inc | 99,600 (-28.8%) | $766K (-33.5%) | 0.4% | $7.69 | $7.86 | — | COM NEW | 45783C200 |
| QURE | Uniqure Nv | 79,407 (-62.5%) | $3.657M (+5.7%) | 2.1% | $46.06 | $23.55 | — | SHS | N90064101 |
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| CMPS | Compass Pathways Plc | 819,692 | $11.6M | 6.7% | $14.15 | $6.90 | — | SPONSORED ADS | 20451W101 |
| XFOR | X4 Pharmaceuticals Inc | 3,722,840 | $17.39M | 10.0% | $4.67 | $3.63 | — | COM NEW | 98420X202 |
| SEPN | Septerna Inc | 194,544 | $6.515M | 3.7% | $33.49 | $23.88 | — | COM | 81734D104 |
| PHVS | Pharvaris NV | 198,772 | $6.874M | 4.0% | $34.58 | $24.09 | — | COM | N69605108 |
| SRZN | Surrozen Inc | 385,178 | $9.995M | 5.7% | $25.95 | $16.18 | — | COM NEW | 86889P208 |
| SION | Sionna Therapeutics Inc | 197,072 | $8.669M | 5.0% | $43.99 | $37.92 | — | COM | 829401108 |
| TYRA | Tyra Biosciences Inc | 74,465 | $2.378M | 1.4% | $31.94 | $18.37 | — | COM | 90240B106 |
| LONA | LeonaBio Inc | 393,701 | $3.618M | 2.1% | $9.19 | $4.58 | — | COM | 04746L203 |
| MLTX | MoonLake Immunotherapeutics | 175,734 | $3.422M | 2.0% | $19.47 | $11.80 | — | CLASS A ORD | 61559X104 |
| GLTO | Damora Therapeutics Inc | 139,000 | $3.615M | 2.1% | $26.01 | $25.80 | — | COM NEW | 36322Q206 |